Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: Results from 6,000 consecutive procedures

Acta Orthopaedica

Volumn 85, Issue 1, 2014, Pages 26-31

  Khan, Sameer K ^a   Malviya, Ajay ^a   Muller, Scott D ^a   Carluke, Ian ^a   Partington, Paul F ^a   Emmerson, Kevin P ^a   Reed, Mike R ^a  

^a NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CEFUROXIME; DEXAMETHASONE; GABAPENTIN; GENTAMICIN; LEVOBUPIVACAINE; OXYCODONE; PARACETAMOL; PARECOXIB; RIVAROXABAN; TEICOPLANIN; TINZAPARIN; TRAMADOL; TRANEXAMIC ACID;

ADULT; AGED; ANESTHETIC RECOVERY; ARTICLE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DRUG MEGADOSE; ENHANCED RECOVERY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HIP ARTHROPLASTY; HOSPITAL READMISSION; HUMAN; KNEE ARTHROPLASTY; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; VERY ELDERLY;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; DELIVERY OF HEALTH CARE; ENGLAND; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT CARE TEAM; PATIENT READMISSION; PERIOPERATIVE CARE; PROGRAM EVALUATION; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84896817216     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453674.2013.874925     Document Type: Article

References (24)

1. Abuzakuk T M, Coward P, Shenava Y, Kumar V S, Skinner J A. The management of wounds following primary lower limb arthroplasty: A prospective, randomized study comparing hydrofibre and central pad dressings. Int Wound J 2006; 3 (2): 133-7.
2. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason J M. Tranexamic acid in total knee replacement: A systematic review and metaanalysis. J Bone Joint Surg (Br) 2011; 93 (12): 1577-85.
3. Aveline C, Leroux A, Vautier P, Cognet F, Le Hetet H, Bonnet F. Risk factors for renal dysfunction after total hip arthroplasty. Ann Fr Anesth Reanim 2009; 28 (9): 728-34.
4. Brämer G R. International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q 1988; 41 (1): 32-6.
5. Clarke J V, Deakin A H, Dillon J M, Emmerson S, Kinninmonth A W. A prospective clinical audit of a new dressing design for lower limb arthroplasty wounds. J Wound Care 2009; 18 (1): 5-8, 10-1.
6. Department of Health. Health Service Circular HSC 2007/001. Better blood transfusion- Safe and appropriate use of blood. London; 2007.
7. Holm B, Kristensen M T, Bencke J, Husted H, Kehlet H, Bandholm T. Loss of knee-extension strength is related to knee swelling after total knee arthroplasty. Arch Phys Med Rehabil 2010; 91: 1770-6.
8. Husted H, Holm G, Jacobsen S. Predictors of length of stay and patient satisfaction after hip and knee replacement surgery: Fast-Track experience in 712 patients. Acta Orthop 2008; 79 (2): 168-73.
9. Husted H, Hansen H C, Holm G, Bach-Dal C, Rud K, Andersen K L, Kehlet H. What determines length of stay after total hip and knee arthroplasty?.A nationwide study in Denmark. Arch Orthop Trauma Surg 2010a; 130 (2): 263-8.
10. Husted H, Otte K S, Kristensen B B, Orsnes T, Kehlet H. Readmissions after fast-Track hip and knee arthroplasty. Arch Orthop Trauma Surg 2010b; 130 (9): 1185-91.
11. Husted H, Otte K S, Kristensen B B, Ørsnes T, Wong C, Kehlet H. Low risk of thromboembolic complications after fast-Track hip and knee arthroplasty. Acta Orthop 2010c; 81 (5): 599-605.
12. Jensen C D, Steval A, Partington P F, Reed M R, Muller S D. Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: A retrospective cohort study. J Bone Joint Surg (Br) 2011; 93 (1): 91-5.
13. Jones R. Costing orthopaedic interventions. Br J Healthcare Management 2008; 14 (12): 539-47.
14. Jones S, Alnaib M, Kokkinakis M, Wilkinson M, St Clair Gibson A, Kader D. Pre-operative patient education reduces length of stay after knee joint arthroplasty. Ann R Coll Surg Engl 2011; 93 (1): 71-5.
15. Larsen K, Hansen T B, Søballe K, Kehlet H. Patient-reported outcome after fast-Track hip arthroplasty: A prospective cohort study. Health Qual Life Outcomes 2010; 8: 144.
16. Malviya A, Martin K, Harper I, Muller S D, Emmerson K P, Partington P F, Reed M R. Enhanced recovery program for hip and knee replacement reduces death rate. Acta Orthop 2011; 82 (5): 577-81.
17. National Electronic Library for Medicines. London and South East Regional Medicines Information Service. 25 January 2010. http://www.nelm.nhs.uk/ en/NeLM-Area/Other-Lib-Updates/Drug-Discontinuation-And-Shortage/ Shortage-of-Tranexamic-Acid-injection-Cyclokapron-injection/. Accessed 20 February 2013.
18. National Institute for Health and Care Excellence. Venous thromboembolism: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. (Clinical guideline CG46) 2007. http://www.nice.org.uk/CG046. Accessed 15 May 2013.
19. National Institute for Health and Care Excellence. Venous thromboembolism: Reducing the risk. Clinical guideline CG92) 2011. http://www.nice.org.uk/ CG092. Accessed 15 May 2013.
20. Nechleba J, Rogers V, Cortina G, Cooney T. Continuous intra-Articular infusion of bupivacaine for postoperative pain following total knee arthroplasty. J Knee Surg 2005; 18 (3): 197-202.
21. NHS Blood and Transplant. Strategic Plan 2012 - 2017. http://www.nhsbt. nhs.uk/strategicplan/blood-components/ (date last accessed 10 Aug 2012). NHS Connecting for Health. OPCS Classification of Interventions and Procedures. Version 4.5. London: TSO, 2009.
22. Schroer W C, Diesfeld P J, LeMarr A R, Reedy M E. Benefits of prolonged postoperative cyclooxygenase-2 inhibitor administration on total knee arthroplasty recovery: A double-blind, placebo-controlled study. J Arthroplasty (6 Suppl) 2011; 26: 2-7.
23. Sprowson A, Symes T, Khan S K, Oswald T, Reed M R. Changing antibiotic prophylaxis for primary joint arthroplasty affects postoperative complication rates and bacterial spectrum. Surgeon 2012 Jun 16. Epub ahead of print
24. Sukeik M, Alshryda S, Haddad F S, Mason J M. Systematic review and metaanalysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg (Br) 2011; 93 (1): 39-46.